RE:RE:Adlai acquiring ONCY?Sundaygenius,
From your post: One common share purchase warrant of USD $6 million whereby, upon exercise, Adlai may purchase Oncolytics' common shares priced at a 120% premium of the five-day weighted average closing price immediately preceding the exercise date. Oncolytics has the right to call this warrant upon the enrollment of the 50th patient in the phase 3 mBC study.
That clause, if you copied it correctly, says they can buy $6 million worth of shares, not all the shares.
If they made an offer for any specfic amount, other bidders would enter and bid the price up.
Clearly you are here to disturb things by spreading manure.